Stocks to Buy: Citi projects 20% upside for a stock that Mutual Funds lapped up in March
Brokerage firm Citi has initiated coverage on Anthem Biosciences Ltd. in its latest note on Tuesday, April 21, with a “buy” recommendation. Citi’s rating comes with a price target...
